Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir/Ritonavir in HIV-1 Infected Children (3 to <6 Years)
NCT00919854Phase 2Completed
- Sponsor
- Tibotec
- Start
- Sep 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Sep 2009; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00919854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919854.